Anti-JNK1 antibody [EPR140(2)]
- 20ul selling size
- RabMAb
- Recombinant
- KO Validated
- What is this?
5
(1 Review)
|
(44 Publications)
Knockout Tested Rabbit Recombinant Monoclonal JNK1 antibody. Suitable for WB and reacts with Human, Mouse, Rat samples. Cited in 44 publications.
View Alternative Names
JNK1, PRKM8, SAPK1, SAPK1C, MAPK8, Mitogen-activated protein kinase 8, MAP kinase 8, MAPK 8, JNK-46, Stress-activated protein kinase 1c, Stress-activated protein kinase JNK1, c-Jun N-terminal kinase 1, SAPK1c
- WB
Lab
Western blot - Anti-JNK1 antibody [EPR140(2)] (AB110724)
All lanes:
Western blot - Anti-JNK1 antibody [EPR140(2)] (ab110724) at 1/2000 dilution
Lane 1:
HEK-293 (Human embryonic kidney epithelial cell) whole cell lysate at 20 µg
Lane 2:
C6 (Rat glial tumor cell line) whole cell lysate at 20 µg
Lane 3:
RAW 264.7 (Mouse Abelson murine leukemia virus-induced tumor macrophage) whole cell lysate at 20 µg
Secondary
All lanes:
Western blot - Goat Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/goat-rabbit-igg-h-l-hrp-ab97051'>ab97051</a>) at 1/20000 dilution
Predicted band size: 48 kDa
Observed band size: 46 kDa,54 kDa
false
- WB
Unknown
Western blot - Anti-JNK1 antibody [EPR140(2)] (AB110724)
All lanes:
Western blot - Anti-JNK1 antibody [EPR140(2)] (ab110724) at 1/1000 dilution
Lane 1:
HeLa cell lysate at 10 µg
Lane 2:
293T cell lysate at 10 µg
Lane 3:
K562 cell lysate at 10 µg
Lane 4:
MCF7 cell lysate at 10 µg
Predicted band size: 48 kDa
false
- WB
Lab
Western blot - Anti-JNK1 antibody [EPR140(2)] (AB110724)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : JNK1 knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : MCF7 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green). Green - ab110724 observed at 46 and 54 kDa. Red - loading control, ab8226, observed at 42 kDa.
ab110724 (unpurified) was shown to specifically react with JNK1 when JNK1 knockout samples were used. Wild-type and ProteinX knockout samples were subjected to SDS-PAGE. ab110724 and ab8226 (loading control to beta actin) were both diluted 1/1000 and incubated overnight at 4°C. Blots were developed with Goat anti-Rabbit IgG H&L (IRDye® 800CW) preadsorbed (ab216773) and Goat anti-Mouse IgG H&L (IRDye® 680RD) preadsorbed (ab216776) secondary antibodies at 1/10 000 dilution for 1 h at room temperature before imaging.
All lanes:
Western blot - Anti-JNK1 antibody [EPR140(2)] (ab110724)
Predicted band size: 48 kDa
false
- WB
Lab
Western blot - Anti-JNK1 antibody [EPR140(2)] (AB110724)
False colour image of Western blot : Anti-JNK1 antibody [EPR140(2)] staining at 1/1000 dilution, shown in green; Mouse anti-GAPDH antibody [6C5] (ab8245) loading control staining at 1/20000 dilution, shown in red. In Western blot, ab110724 was shown to bind specifically to JNK1. A band was observed at 42/48 kDa in wild-type U-2 OS cell lysates with no signal observed at this size in mapk8 knockout cell line ab277181 (knockout cell lysate ab277223). To generate this image, wild-type and mapk8 knockout U-2 OS cell lysates were analysed. First, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5 % milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged. Secondary antibodies used were Goat anti-Rabbit IgG H&L 800CW and Goat anti-Mouse IgG H&L 680RD at 1/20000 dilution.
All lanes:
Western blot - Anti-JNK1 antibody [EPR140(2)] (ab110724) at 1/1000 dilution
Lane 1:
Wild-type U-2 OS cell lysate at 20 µg
Lane 2:
MAPK8 knockout U-2 OS cell lysate at 20 µg
Observed band size: 42-48 kDa
false
- WB
Lab
Western blot - Anti-JNK1 antibody [EPR140(2)] (AB110724)
Lane 1 : Wild-type HAP1 cell lysate (20 μg)
Lane 2 : JNK1 knockout HAP1 cell lysate (20 μg)
Lane 3 : HeLa cell lysate (20 μg)
Lane 4 : MCF7 cell lysate (20 μg)
Lanes 1 - 4 : Merged signal (red and green).
Green - target observed at 46 and 54 kDa. Red - loading control, ab8226, observed at 42 kDa.
This western blot image is a comparison between ab110724 and a competitor's top cited mouse monoclonal antibody.
All lanes:
Western blot - Anti-JNK1 antibody [EPR140(2)] (ab110724)
Predicted band size: 48 kDa
false
- WB
Lab
Western blot - Anti-JNK1 antibody [EPR140(2)] (AB110724)
Western blot : Rabbit Monoclonal [EPR140(2)] to JNK1 ab110724 staining at 1/1000 dilution, shown in green; Mouse anti-CANX (ab238078) loading control staining at 1/20,000 dilution, shown in magenta.
A band was observed at 42 kDa in Wild-type A549 cell lysates with no signal observed at this size in MAPK8 knockout A549 cell line.
To generate this image, samples were run on an SDS-PAGE gel then transferred onto a nitrocellulose membrane. Membranes were blocked in 5pc Milk in TBS-0.1 % Tween® 20 (TBS-T) before incubation with primary antibodies overnight at 4 °C. Blots were washed four times in TBS-T, incubated with secondary antibodies for 1 h at room temperature, washed again four times then imaged.
Secondary antibodies used were Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20,000 dilution.
All lanes:
Western blot - Anti-JNK1 antibody [EPR140(2)] (ab110724) at 1/1000 dilution
Lane 1:
Wild-type A549 at 20 µg
Lane 2:
MAPK8 knockout A549 at 20 µg
Lane 2:
Western blot - Human MAPK8 knockout A549 cell line (ab286604) at 20 µg
Lane 3:
Wild-type U-2 OS at 20 µg
Lane 4:
MAPK8 knockout U-2 OS at 20 µg
Secondary
All lanes:
Goat anti-Rabbit 800CW & Goat anti-Mouse 680RD at 1/20000 dilution
Predicted band size: 48 kDa
Observed band size: 42 kDa
false
Related conjugates and formulations (1)
-
Anti-JNK1 antibody [EPR140(2)] - BSA and Azide free
Reactivity data
Product details
Patented technology
Our RabMAb® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb® patents.
What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:
- - High batch-to-batch consistency and reproducibility
- - Improved sensitivity and specificity
- - Long-term security of supply
- - Animal-free batch production
For more information, read more on recombinant antibodies.
Properties and storage information
Form
Purification technique
Storage buffer
Shipped at conditions
Appropriate short-term storage duration
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
This kinase plays an important role in processes such as inflammation apoptosis and cellular stress responses. JNK1 is not just an isolated enzyme. It forms complexes with other proteins under specific conditions facilitating diverse cellular responses. For example JNK1 activation influences transcription factors like c-Jun by phosphorylating them impacting gene expression related to cell survival and death. This activity establishes JNK1 as a significant player in routine cell functioning and response to external environmental stressors.
Pathways
The kinase is part of the MAPK signaling pathways and the stress-activated protein kinase (SAPK) pathways. These pathways involve multiple signaling cascades important for transmitting extracellular signals into the cellular environment. JNK1 interacts with proteins like MKK4 and MKK7 which are upstream activators and ATF2 a downstream target. This positioning makes JNK1 an essential signaling node that translates extracellular stressors into cellular responses providing adaptability to cells amidst changing conditions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (44)
Recent publications for all applications. Explore the full list and refine your search
OncoTargets and therapy 17:471-487 PubMed38895133
2024
Applications
Unspecified application
Species
Unspecified reactive species
Journal of biochemical and molecular toxicology 38:e23682 PubMed38462752
2024
Applications
Unspecified application
Species
Unspecified reactive species
Allergologia et immunopathologia 52:60-67 PubMed38459892
2024
Applications
Unspecified application
Species
Unspecified reactive species
Frontiers in medicine 9:697644 PubMed35860733
2022
Applications
Unspecified application
Species
Unspecified reactive species
Global spine journal 13:2396-2408 PubMed35400210
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular medicine reports 24: PubMed34713293
2021
Applications
Unspecified application
Species
Unspecified reactive species
Experimental and therapeutic medicine 22:1401 PubMed34650647
2021
Applications
Unspecified application
Species
Unspecified reactive species
Diabetology & metabolic syndrome 13:89 PubMed34446088
2021
Applications
Unspecified application
Species
Unspecified reactive species
International journal of endocrinology 2021:5583491 PubMed34035807
2021
Applications
Unspecified application
Species
Unspecified reactive species
Oncology letters 21:486 PubMed33968202
2021
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com